MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic Targets

Author(s): Athanassios Kotsinas, Fragkiska Sigala, Spiros D. Garbis, Giorgos Galyfos, Konstantinos Filis, Konstantinos Vougas, Alexandros Papalampros, Elizabeth E. Johnson, Efstathios Chronopoulos, Alexandros G. Georgakilas, Vassilis G. Gorgoulis

Journal Name: Current Medicinal Chemistry

Volume 22 , Issue 22 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Cardiovascular diseases (CVDs) have become a predominant cause of death worldwide. Although CVDs encompass a variety of pathological conditions that affect the heart and blood vasculature, they can be classified into two major groups according to their basic pathophysiologic mechanisms, namely atherosclerosis and aneurysm formation. Increasing evidence implicates micro-RNAs (miRNAs or miRs) as vital factors both in the initiation and progression processes of CVDs. Some miRs have a promoting role in CVD development, while others have a protective role. Today, miRs have been shown to be potential biomarkers for several types of CVDs, while strategies targeting miRs are under consideration as potential tools for exploitation in therapeutic approaches for CVD treatments. In this review, we present the available data on the involvement of miRs in CVDs, focusing on their role as regulators of the inflammatory process as an initiating and driving component of CVDs.

Keywords: Biomarkers, cardiovascular disease, inflammation, miRNAs.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 12 August, 2015
Page: [2666 - 2679]
Pages: 14
DOI: 10.2174/0929867322666150716113304
Price: $65

Article Metrics

PDF: 52